HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Positive effect of low-dose imatinib mesylate in a patient with nephrogenic systemic fibrosis.

AuthorsTina Rask Elmholdt, Michael Pedersen, Bettina Jørgensen, Mette Ramsing, Anne Braae Olesen
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 91 Issue 4 Pg. 478-9 (Jun 2011) ISSN: 1651-2057 [Electronic] Sweden
PMID21537826 (Publication Type: Case Reports, Letter)
Chemical References
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
Topics
  • Adult
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Joints (drug effects, physiopathology)
  • Male
  • Nephrogenic Fibrosing Dermopathy (diagnosis, drug therapy, physiopathology)
  • Piperazines (administration & dosage)
  • Protein Kinase Inhibitors (administration & dosage)
  • Pyrimidines (administration & dosage)
  • Range of Motion, Articular
  • Recovery of Function
  • Severity of Illness Index
  • Skin (drug effects, pathology)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: